title: Inversion of the intracellular Na(+)/K(+) ratio blocks apoptosis in vascular smooth muscle cells by induction of RNA synthesis.
abstract: This study examines the involvement of RNA and protein synthesis in the modulation of apoptosis in vascular smooth muscle cells (VSMC) by intracellular monovalent cations. In VSMC transfected with E1A adenovirus (VSMC-E1A), inversion of the [Na(+)](i)/[K(+)](i) ratio by an inhibitor of the Na(+),K(+) pump, ouabain, prevented the development of apoptosis triggered by serum withdrawal. Inhibition of apoptosis by ouabain was abolished by inhibitors of RNA and protein synthesis, actinomycin D, and cycloheximide, respectively. In VSMC-E1A, incubation with ouabain for 4 and 24 hours augmented RNA synthesis by 20% to 50% and 3-fold to 4-fold, respectively. In quiescent VSMC, the effect of ouabain and serum on RNA synthesis was additive. Ouabain did not affect the level of phosphorylation of ERK, JNK, and p38 MAP kinases and blocked apoptosis independent of the presence of the MAPK kinase inhibitors PD98059 and SB 202190. Equimolar substitution of NaCl with KCl in the incubation medium abolished the effect of ouabain on intracellular Na(+) and K(+) concentration, apoptosis, and RNA synthesis. Thus, our results demonstrate that the antiapoptotic effect of the inverted [Na(+)](i)/[K(+)](i) ratio is mediated by MAPK-independent induction of de novo synthesis of RNA species encoding inhibitor(s) of programmed cell death.
authors.affiliation: Centre de Recherché du CHUM, Campus Hotel-Dieu, University of Montreal, Montreal, PQ, Canada. sergei.n.orlov@umontreal.ca
authors.forename: S N
authors.initials: SN
authors.lastname: Orlov
authors.forename: S
authors.initials: S
authors.lastname: Taurin
authors.forename: N
authors.initials: N
authors.lastname: Thorin-Trescases
authors.forename: N O
authors.initials: NO
authors.lastname: Dulin
authors.forename: J
authors.initials: J
authors.lastname: Tremblay
authors.forename: P
authors.initials: P
authors.lastname: Hamet
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology*; D002478:Cells, Cultured; D017136:Ion Transport / Q000187:drug effects; D020935:MAP Kinase Signaling System; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000473:pathology* / Q000502:physiology*; D010042:Ouabain / Q000494:pharmacology; D011188:Potassium / Q000502:physiology*; D012313:RNA / Q000096:biosynthesis; D051381:Rats; D011914:Rats, Inbred BN; D012964:Sodium / Q000502:physiology*; D000254:Sodium-Potassium-Exchanging ATPase / Q000502:physiology
chemical_list: D010042:Ouabain; D012313:RNA; D012964:Sodium; D000254:Sodium-Potassium-Exchanging ATPase; D011188:Potassium